Tue, June 9, 2020
Mon, June 8, 2020
Fri, June 5, 2020

Konstantinos Aprilakis Maintained (BPMC) at Strong Buy with Increased Target to $85 on, Jun 8th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-85-on-jun-8th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Konstantinos Aprilakis of Deutsche Bank, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Increased Target from $70 to $85 on, Jun 8th, 2020.

Konstantinos has made no other calls on BPMC in the last 4 months.



There are 5 other peers that have a rating on BPMC. Out of the 5 peers that are also analyzing BPMC, 1 agrees with Konstantinos's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Peter Lawson of "Barclays" Initiated at Hold and Held Target at $59 on, Tuesday, May 5th, 2020


These are the ratings of the 4 analyists that currently disagree with Konstantinos


  • Andrew Berens of "Morgan Stanley" Maintained at Buy with Decreased Target to $88 on, Thursday, April 30th, 2020
  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $100 on, Thursday, April 30th, 2020
  • George Farmer of "BMO Capital" Maintained at Buy with Decreased Target to $75 on, Wednesday, April 29th, 2020
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $66 on, Wednesday, April 29th, 2020